1.3(top 50%)
impact factor
1.1K(top 20%)
papers
21.5K(top 10%)
citations
65(top 10%)
h-index
1.4(top 50%)
impact factor
1.4K
all documents
22.8K
doc citations
109(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based BiosensorsAssay and Drug Development Technologies20141,793
2Molecular Interaction Studies Using Microscale ThermophoresisAssay and Drug Development Technologies2011655
3Bioluminescent Assays for High-Throughput ScreeningAssay and Drug Development Technologies2007369
4Zebrafish: A Preclinical Model for Drug ScreeningAssay and Drug Development Technologies2002351
5Application of Real-Time Cell Electronic Sensing (RT-CES) Technology to Cell-Based AssaysAssay and Drug Development Technologies2004343
6Improving the Solubility and Pharmacological Efficacy of Curcumin by Heat TreatmentAssay and Drug Development Technologies2007266
7Use of Multiple Assay Endpoints to Investigate the Effects of Incubation Time, Dose of Toxin, and Plating Density in Cell-Based Cytotoxicity AssaysAssay and Drug Development Technologies2004260
8Extracellular Matrix Remodeling: The Common Denominator in Connective Tissue DiseasesPossibilities for Evaluation and Current Understanding of the Matrix as More Than a Passive Architecture, but a Key Player in Tissue FailureAssay and Drug Development Technologies2013226
9ADP-Glo: A Bioluminescent and Homogeneous ADP Monitoring Assay for KinasesAssay and Drug Development Technologies2009198
10Label-Free Cell-Based Assays with Optical Biosensors in Drug DiscoveryAssay and Drug Development Technologies2006189
11Advances in High Content Screening for Drug DiscoveryAssay and Drug Development Technologies2003182
12Dynamic and Label-Free Cell-Based Assays Using the Real-Time Cell Electronic Sensing SystemAssay and Drug Development Technologies2006163
13A FRET-Based Assay Platform for Ultra-High Density Drug Screening of Protein Kinases and PhosphatasesAssay and Drug Development Technologies2002147
14High-Content Assays for Characterizing the Viability and Morphology of 3D Cancer Spheroid CulturesAssay and Drug Development Technologies2015135
15High Throughput Screening Technologies for Direct Cyclic AMP MeasurementAssay and Drug Development Technologies2003133
16Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage DisordersAssay and Drug Development Technologies2011130
17A Robotic Platform for Quantitative High-Throughput ScreeningAssay and Drug Development Technologies2008126
18High Throughput Assay Technologies for Ion Channel Drug DiscoveryAssay and Drug Development Technologies2004120
19High-Throughput Screening with Quantitation of ATP Consumption: A Universal Non-Radioisotope, Homogeneous Assay for Protein KinaseAssay and Drug Development Technologies2004118
20Thermal Denaturation Assays in Chemical BiologyAssay and Drug Development Technologies2012118
21AlphaLISA Immunoassay Platform— The “No-Wash” High-Throughput Alternative to ELISAAssay and Drug Development Technologies2009114
22The Cellular Distribution of Fluorescently Labeled Arrestins Provides a Robust, Sensitive, and Universal Assay for Screening G Protein-Coupled ReceptorsAssay and Drug Development Technologies2002112
23High Throughput Ion-Channel Pharmacology: Planar-Array-Based Voltage ClampAssay and Drug Development Technologies2003111
24High-Content Assays for Hepatotoxicity Using Induced Pluripotent Stem Cell–Derived CellsAssay and Drug Development Technologies2014111
25In Vitro, Ex Vivo, andIn VivoMethodological Approaches for Studying Therapeutic Targets of Osteoporosis and Degenerative Joint Diseases: How Biomarkers Can Assist?Assay and Drug Development Technologies2005107
26A High Throughput Luminescent Assay for Glycogen Synthase Kinase-3β InhibitorsAssay and Drug Development Technologies2007107
27High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and HepatocytesAssay and Drug Development Technologies2015107
28Development of a 384-Well Colorimetric Assay to Quantify Hydrogen Peroxide Generated by the Redox Cycling of Compounds in the Presence of Reducing AgentsAssay and Drug Development Technologies2008106
29Scintillation Proximity Assays in High-Throughput ScreeningAssay and Drug Development Technologies2008105
30Label-Free Cytotoxicity Screening Assay by Digital Holographic MicroscopyAssay and Drug Development Technologies2013105
31HTS Identifies Novel and Specific Uncompetitive Inhibitors of the Two-Component NS2B-NS3 Proteinase of West Nile VirusAssay and Drug Development Technologies200795
32Primary Cells and Stem Cells in Drug Discovery: Emerging Tools for High-Throughput ScreeningAssay and Drug Development Technologies201194
33Profiling the NIH Small Molecule Repository for Compounds That Generate H2O2by Redox Cycling in Reducing EnvironmentsAssay and Drug Development Technologies201093
34The Zebrafish: A Powerful Platform forIn Vivo, HTS Drug DiscoveryAssay and Drug Development Technologies201191
35Enzyme Fragment Complementation: A Flexible High Throughput Screening Assay TechnologyAssay and Drug Development Technologies200290
36Biophysical Methods for Monitoring Cell-Substrate Interactions in Drug DiscoveryAssay and Drug Development Technologies200390
37Characterization of Potassium Channel Modulators with QPatch™ Automated Patch-Clamp Technology: System Characteristics and PerformanceAssay and Drug Development Technologies200389
38Emerging Concepts of Guanine Nucleotide-Binding Protein-Coupled Receptor (GPCR) Function and Implications for High Throughput ScreeningAssay and Drug Development Technologies200789
39Impedance-Based Detection of Beating Rhythm and Proarrhythmic Effects of Compounds on Stem Cell-Derived CardiomyocytesAssay and Drug Development Technologies201189
40Computational and Practical Aspects of Drug RepositioningAssay and Drug Development Technologies201589
41Automated Tight Seal Electrophysiology for Assessing the Potential hERG Liability of Pharmaceutical CompoundsAssay and Drug Development Technologies200486
42Drug Discovery Approaches Utilizing Three-Dimensional Cell CultureAssay and Drug Development Technologies201685
43An Automated Liquid Chromatography-Mass Spectrometry Process to Determine Metabolic Stability Half-Life and Intrinsic Clearance of Drug Candidates by Substrate DepletionAssay and Drug Development Technologies200883
44Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image AnalysisAssay and Drug Development Technologies201683
45Functional Assay of Voltage-Gated Sodium Channels Using Membrane Potential-Sensitive DyesAssay and Drug Development Technologies200481
46Kinetic Exclusion Assay Technology: Characterization of Molecular InteractionsAssay and Drug Development Technologies200479
47Cellular Dielectric Spectroscopy: A Label-Free Comprehensive Platform for Functional Evaluation of Endogenous ReceptorsAssay and Drug Development Technologies200679
48High-Content Assay to Identify Inhibitors of Dengue Virus InfectionAssay and Drug Development Technologies201078
49Characterization of a hERG Screen Using the IonWorks HT: Comparison to a hERG Rubidium Efflux ScreenAssay and Drug Development Technologies200577
50βGalactosidase Complementation: A Cell-Based Luminescent Assay Platform for Drug DiscoveryAssay and Drug Development Technologies200777